Rituximab plus reduced-dose cyclophosphamide, doxorubicin, vincristine and prednisone (RD R-CHOP) chemotherapy is feasible for very elderly patients (≥80 years) with B-cell lymphoma: analysis of treatment outcome
Shi, Zhan, Tang, Xi, Wang, Jingwen, Shen, Qianwen, Chen, Xi, Chen, Jiayan, Zhuang, JieLanguage:
english
Journal:
Journal of Chemotherapy
DOI:
10.1080/1120009X.2016.1196869
Date:
June, 2016
File:
PDF, 722 KB
english, 2016